These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38073309)

  • 1. A systematic review of undifferentiated pleomorphic sarcoma of the chest wall.
    Bennett C; Bharadwaj S; Arndt A; Chawla A
    Chin Clin Oncol; 2023 Dec; 12(6):66. PubMed ID: 38073309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
    Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
    Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
    Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
    J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
    Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
    J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and genetic characterization of radiotherapy-induced undifferentiated pleomorphic sarcoma following breast cancer: a case series of three tumors and comprehensive literature review.
    Lei T; Shen Z; Shen M; Du L; Shi Y; Peng Y; Zhou Z; Da W; Chen X; Li Q
    Diagn Pathol; 2024 Aug; 19(1):110. PubMed ID: 39143618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
    Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
    ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection of chest wall sarcomas: an analysis of survival and predictors of outcome at an Australian multidisciplinary sarcoma service.
    Thakur S; Choong E; Balasooriya A; Spelman T; Wright G; Choong P
    ANZ J Surg; 2022 Oct; 92(10):2613-2619. PubMed ID: 35818677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence patterns after resection of soft tissue sarcomas of the chest wall.
    McMillan RR; Sima CS; Moraco NH; Rusch VW; Huang J
    Ann Thorac Surg; 2013 Oct; 96(4):1223-1228. PubMed ID: 23891404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of undifferentiated pleomorphic sarcoma of a retro-gastric origin, case report and review of literature.
    Almalki W; Alzahrani M; Alssaqqaf I; Baker B
    Int J Surg Case Rep; 2021 Dec; 89():106555. PubMed ID: 34839115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary chest wall sarcoma; a single institution experience of 3 years.
    Gangopadhyay A; Nandy K; Puj K; Sharma M; Jayaprakash D; Salunke A; Jain A; Pandya S
    Cancer Treat Res Commun; 2021; 27():100326. PubMed ID: 33524850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of re-staging chest CT at first local recurrence of extremity and trunk soft tissue sarcoma.
    Baig MS; Habib W; Attard V; Sharif B; Lindsay D; Upadhyay B; Saifuddin A
    Eur Radiol; 2021 Apr; 31(4):2377-2383. PubMed ID: 33037910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use.
    Jeon WJ; Moon JH; Pham B; Joung B; Denham L; Brothers J
    Front Oncol; 2023; 13():1198292. PubMed ID: 37427109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors.
    van Geel AN; Wouters MW; Lans TE; Schmitz PI; Verhoef C
    World J Surg; 2011 Jan; 35(1):63-9. PubMed ID: 20857106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
    Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.